These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35606811)

  • 1. Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial.
    Jiang N; Zhao Y; Stensson M; Mårtensson J
    BMC Oral Health; 2022 May; 22(1):199. PubMed ID: 35606811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region.
    Porangaba LP; de Melo Garcia F; Rabelo APAA; Andrade AP; de Abreu Alves F; Pellizzon ACA; Jaguar GC
    Curr Oncol; 2024 Feb; 31(2):1102-1112. PubMed ID: 38392076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes on salivary flow rates, buffering capacity and chromogranin A levels in adults after bariatric surgery.
    Kogawa EM; Melo FF; Pires RG; Caetano PCC; de Lima Rodrigues J; Benito LAO; da Silva ICR; de Castro Cantuária AP; de Carvalho Sales-Peres SH
    Clin Oral Investig; 2024 Feb; 28(3):159. PubMed ID: 38378939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
    Jakobsen KK; Carlander AF; Grønhøj C; Todsen T; Melchiors J; Paaske N; Madsen AKØ; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggard CD; von Buchwald C
    Trials; 2023 Sep; 24(1):567. PubMed ID: 37658468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study.
    Lopez-Garzon M; López-Fernández MD; Ruíz-Martínez AM; Galván-Banqueri P; Lozano-Lozano M; Tovar-Martín I; Postigo-Martin P; Ariza-Vega P; Artacho-Cordón F; Fernández-Lao C; Cantarero-Villanueva I; Fernández-Gualda MÁ; Arroyo-Morales M; Ruíz-Villaverde R; Galiano-Castillo N
    BMJ Open; 2024 Jan; 14(1):e078068. PubMed ID: 38267245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical analysis of saliva in head and neck cancer patients receiving definitive chemoradiotherapy.
    Rani S; Singh K; Banipal RPS; Goyal G
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S669-S676. PubMed ID: 38384037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of photobiomodulation therapy (PBMT) on salivary flow and composition in head and neck cancer patients undergoing radiation therapy.
    Schepanski N; Costa FS; Machado EFM; Pacheco MN; Amaral CDB; Machado RC; Nogueira ARA; Brancher JA; Sassi LM; de Araujo MR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):253-263. PubMed ID: 38218654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of an integrated supportive programme on oral health in patients with head and neck cancer undergoing radiotherapy: A randomized controlled trial.
    Jiang N; Zhao Y; Mårtensson J; Stensson M
    Int J Dent Hyg; 2024 Apr; ():. PubMed ID: 38656048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
    Blitzer GC; Paz C; Glassey A; Ganz OR; Giri J; Pennati A; Meyers RO; Bates AM; Nickel KP; Weiss M; Morris ZS; Mattison RJ; McDowell KA; Croxford E; Chappell RJ; Glazer TA; Rogus-Pulia NM; Galipeau J; Kimple RJ
    Radiother Oncol; 2024 Mar; 192():110093. PubMed ID: 38224919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does laser photobiomodulation prevent hyposalivation in patients undergoing head and neck radiotherapy? A systematic review and meta-analysis of controlled trials.
    Louzeiro GC; Teixeira DDS; Cherubini K; de Figueiredo MAZ; Salum FG
    Crit Rev Oncol Hematol; 2020 Dec; 156():103115. PubMed ID: 33039721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
    Moral Nakamura D; da Graça Pinto H; Baena Elchin C; Thomazotti Berard L; Abreu Alves F; Azeredo Alves Antunes L; Pena Coto N
    Radiother Oncol; 2023 Sep; 186():109715. PubMed ID: 37207874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of low-level laser therapy on the quality of life of patients with xerostomia undergoing head and neck radiotherapy: a systematic review.
    Ribeiro LN; de Vasconcelos Carvalho M; de Oliveira Limirio JPJ; do Egito Vasconcelos BC; Moraes SLD; Pellizzer EP
    Support Care Cancer; 2024 Jan; 32(2):118. PubMed ID: 38244087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Effect of Photobiomodulation on Radiation-Induced Xerostomia in Head and Neck Cancer Patients: A Randomized Clinical Trial.
    Mosannen Mozaffari P; Delavarian Z; Fekrazad R; Fani Pakdel A; Rashed Mohassel M; Taghi Shakeri M; Ghazi A
    J Lasers Med Sci; 2024; 15():e4. PubMed ID: 38655042
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    van Rijn-Dekker MI; la Bastide-van Gemert S; Stokman MA; Vissink A; Coppes RP; Langendijk JA; van Luijk P; Steenbakkers RJHM
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):772-782. PubMed ID: 38631537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial.
    Strojan P; Plavc G; Kokalj M; Mitrovic G; Blatnik O; Lezaic L; Socan A; Bavec A; Tesic N; Hartman K; Svajger U
    Radiol Oncol; 2023 Dec; 57(4):538-549. PubMed ID: 38038413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of very late xerostomia in head and neck cancer patients after irradiation.
    Blitzer GC; Rogus-Pulia NM; Paz C; Nickel KP; Cannaday VL; Kelm-Nelson CA; Sudakaran S; Chappell RJ; Glazer T; Kimple RJ
    Laryngoscope Investig Otolaryngol; 2022 Aug; 7(4):1018-1024. PubMed ID: 36000048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Photobiomodulation effect of 980 nm Diode Laser on Patients with Xerostomia.
    Derikvand N; Basirat M; Ghasemi SS; Hashemi R
    Lasers Med Sci; 2023 Dec; 39(1):10. PubMed ID: 38117359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1% malic acid spray on diabetes mellitus-induced xerostomia: A randomized clinical trial.
    Muhamed SA; Moussa EM; Aboasy NK; Gaweesh YY
    Oral Dis; 2024 Mar; 30(2):631-638. PubMed ID: 35913424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of Salivary Flow Rate and Sleep Quality among Head and Neck Cancer Survivors after Radiotherapy.
    Shen YW; Wang WC; Lin NC; Ningrum V; Shieh TM; Shih YH
    BMC Oral Health; 2024 Feb; 24(1):251. PubMed ID: 38373984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical pilocarpine for xerostomia in patients with head and neck cancer treated with radiotherapy.
    Pereira RMS; Bastos MDR; Ferreira MP; de Freitas O; de Macedo LD; de Oliveira HF; Ricz HMA; Motta ACF; Macedo AP; Tirapelli C; Pedrazzi V
    Oral Dis; 2020 Sep; 26(6):1209-1218. PubMed ID: 32248594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.